Nomura Asset Management
CRL icon

Nomura Asset Management’s Charles River Laboratories CRL Stock Holding History

Nomura Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Sell
1,376
-345
-20% -$61.4K ﹤0.01% 842
2026
Q1 		$297K Buy
1,721
+301
+21% +$55.8K ﹤0.01% 858
2025
Q4 		$283K Sell
1,420
-6
-0.4% -$1.09K ﹤0.01% 860
2025
Q3 		$223K Buy
1,426
+151
+12% +$24K ﹤0.01% 878
2025
Q2 		$193K Sell
1,275
-10
-0.8% -$1.33K ﹤0.01% 877
2025
Q1 		$193K Sell
1,285
-14,409
-92% -$2.42M ﹤0.01% 887
2024
Q4 		$2.9M Buy
15,694
+102
+0.7% +$19.6K 0.01% 681
2024
Q3 		$3.07M Buy
15,592
+1,882
+14% +$391K 0.01% 673
2024
Q2 		$2.83M Buy
13,710
+132
+1% +$29.9K 0.01% 656
2024
Q1 		$3.68M Sell
13,578
-103
-0.8% -$24.6K 0.01% 610
2023
Q4 		$3.23M Buy
13,681
+1,261
+10% +$248K 0.01% 640
2023
Q3 		$2.43M Sell
12,420
-60
-0.5% -$12.3K 0.01% 666
2023
Q2 		$2.62M Sell
12,480
-366
-3% -$72.8K 0.01% 667
2023
Q1 		$2.59M Buy
12,846
+895
+7% +$203K 0.01% 649
2022
Q4 		$2.6M Buy
11,951
+74
+0.6% +$16.2K 0.02% 631
2022
Q3 		$2.34M Buy
11,877
+828
+7% +$179K 0.01% 639
2022
Q2 		$2.36M Buy
11,049
+71
+0.6% +$17.3K 0.01% 663
2022
Q1 		$3.12M Buy
10,978
+652
+6% +$201K 0.02% 621
2021
Q4 		$3.89M Buy
10,326
+220
+2% +$85.5K 0.02% 564
2021
Q3 		$4.17M Buy
10,106
+600
+6% +$249K 0.02% 517
2021
Q2 		$3.52M Buy
+9,506
New +$3.17M 0.02% 578

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Nomura Asset Management's CRL Position: Q2 2026 in Review

Nomura Asset Management reduced its Charles River Laboratories (CRL) stake by 20% in Q2 2026, selling an estimated $61.4K and leaving 1,376 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #842.

Nomura Asset Management first reported a position in CRL in Q2 2021 and has held it in 21 quarters since. The position peaked at $4.17M in Q3 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Nomura Asset Management held 1,376 shares of Charles River Laboratories worth $312K as of Q2 2026.
  • Nomura Asset Management sold 345 Charles River Laboratories shares in Q2 2026, an estimated $61.4K.
  • Charles River Laboratories made up ﹤0.01% of Nomura Asset Management's portfolio in Q2 2026, its #842 holding.
  • Nomura Asset Management first reported a position in Charles River Laboratories in Q2 2021 and has held it in 21 quarters since.
  • Nomura Asset Management's Charles River Laboratories position peaked at $4.17M in Q3 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.